▾

External sources (not reviewed)

[...] to launch the new 4-yearcurriculum in 2012, it would be prudent at present to concentrate central and Faculty attention and effort on the Ug curriculumreform.

With the support ofnew investors, the IPDiA team created this independent company to serve newmarkets, following [...][...]

[...] [...] that: the acquisition is expected to close in the fourth quarter of 2012; the acquisition of Power Analog Microelectronics will strengthen our position as a global provider of high-quality analog products [...][...]

One NGO urged that UNESCO strengthen its in-house and partnership capacity to tackle the numerous issues related to higher education, such as funding; the responsibilities of higher education towards society and the world of work; quality and access; and innovation, research and relevance.

[...] [...] latest success storyfrom WestAfrica.

[...] [...] against the lateleader of theIslamicRevolution andofficials of [...]

[...] [...] globalization; theuse ofnew technologies and [...][...]

By analysing data such as the origin of requests and the level of demand for particular products and stories, the Department obtained more accurate information and improved its production planning.

We are also encouraged by those Governments that, since the adoption of the Durban Declaration and Programme of Action, have adopted landmark and progressive legislative and administrative measures effectively to combat racism and racial discrimination, to protect the rights of migrants and racial, national or ethnic and linguistic minorities, and to combat incitement to hatred based on religion or belief.

In the private sector, progressive companies are moving away from the voluntarism of “corporate social responsibility” and towards much harder-edged, genuinely systemic approaches — both in their own activities (such as mainstreaming sustainability in supply chains through the use of standards or joining voluntary emissions trading markets) and in their public policy lobbying (for example, coalitions of companies demanding tougher emissions targets and greater long-term certainty in environmental regulation and pricing).

Moreover, since we are not just interested in the dynamic effect of IPRs in promoting innovation, but also the costs that IP protection imposes on society, particularly on poor people, we need to take account of these costs in considering the evidence and the value of any given IP system.

[...] [...] caps forthe NewProduct Supply Agreement was more than 0.1% but less than 5%, the continuing connected transactions under the NewProductSupply [...][...]

Since each of the applicable percentage ratios (other than the profits ratio) calculated with reference to the Aggregated Annual Caps is less than 5%, the continuing connected transactions contemplated under the Renewed Product Supply Agreement andRenewed Master Supply Agreement are only subject to the reporting, announcement and annual review requirements and exempt from the independent shareholders’ approval requirement under Rule 14A.34 of the Listing Rules.

Consular office networks for identifying and assisting migrants in vulnerable situations should be strengthened, and sustainable reintegration programmes and related inter-State cooperation to help re-establish returnees in their home communitiesand prevent “re-migration” should be pursued.

In this context, They welcomed the overwhelming support received by Non-Aligned Movement’s UNGA resolution 65/66 entitled “Convening of the fourth special session of the General Assembly devoted to disarmament” They urged the UN Secretary-General to make available all necessary technical, financial and human resources to implement the resolution.

Our systematically acquired knowledge, more than 1000 formulations and the innovative power of our entire group guarantee absolute customer orientation, tailored products and solutions in line with market conditions.

The bargain with society is precisely that the benefits to society generated by the extra innovation induced (for example, a lifesaving drug which might not exist but for the patent system) should exceed the extra cost of the product.